Abiopharma

🔍 STARKS DANIEL J (Executive)

Company: ABBOTT LABORATORIES (ABT)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Acquired 2,286 shares of Common shares without par value (Direct)
  Date: 2026-04-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,741,103.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 10,000 shares of Common shares without par value at $92.6537 per share (Direct)
  Date: 2026-04-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 6,751,103.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common shares without par value (Direct)
  Date: 2026-04-24 | Code: H | nature_of_ownership: Alynne Starks 2012 Irrevocable Trust | shares_owned_after: 258.00 | Footnotes: F3
• Acquired 7,105 shares of Option (right to buy) at $91.86 per share (Derivative)
  Date: 2026-04-24 | Code: A | Expires: 2036-04-23 | Exercise: 2026-04-24 | equity_swap_involved: 0 | shares_owned_after: 7,105.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.43 to $93.04, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F3: Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.
• F4: Stock option granted under the Program, in a transaction exempt from Section 16 under Rule 16b-3.